Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 10-K | 10-K | 10-K | 10-K | S-1/A |
| Revenues: |
| United States | 37.6 | 34.8 | | | |
| Other | 9.3 | 7.4 | | | |
| Revenues | 46.9 | 42.2 | 26.9 | | 22.1 |
| Revenue growth [+] | 11.0% | 56.9% | | | |
| United States | 8.1% | | | | |
| Cost of goods sold | 20.8 | 19.0 | 12.0 | | 9.7 |
| Gross profit | 26.0 | 23.2 | 14.9 | | 12.4 |
| Gross margin | 55.5% | 55.0% | 55.5% | | 56.2% |
| Selling, general and administrative | 43.9 | 32.2 | 12.5 | | 9.3 |
| Research and development | 17.5 | 13.1 | 8.2 | | 9.5 |
| EBITDA [+] | -33.8 | -21.1 | -5.0 | | -5.5 |
| EBITDA growth | 59.7% | 324.2% | | | |
| EBITDA margin | -72.1% | -50.1% | -18.5% | | -25.1% |
| Depreciation | 1.3 | 0.9 | 0.8 | | 0.9 |
| EBITA | -35.0 | -22.1 | -5.8 | | -6.4 |
| EBITA margin | -74.8% | -52.3% | -21.6% | | -29.2% |
| Amortization of intangibles | 0.3 | | | | |
| EBIT [+] | -35.4 | -22.1 | -5.8 | | -6.4 |
| EBIT growth | 60.3% | 279.5% | | | |
| EBIT margin | -75.5% | -52.3% | -21.6% | | -29.2% |
| Interest expense, net [+] | -1.9 | -0.1 | 1.0 | | 1.1 |
| Interest expense | 0.1 | 0.5 | 1.0 | | 1.1 |
| Interest income | 2.0 | 0.5 | | | |
| Other income (expense), net | -0.1 | -0.2 | -6.0 | | 0.0 |
| Pre-tax income | -33.6 | -22.2 | -12.8 | | -7.6 |
| Income taxes | 0.0 | 0.0 | 0.0 | | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | | 0.0% |
| Net income | -33.6 | -22.2 | -12.9 | | -7.6 |
| Net margin | -71.7% | -52.6% | -48.0% | | -34.5% |
| |
| Basic EPS [+] | ($1.07) | ($0.79) | ($2.35) | | ($1.55) |
| Growth | 34.4% | -66.3% | | | |
| Diluted EPS [+] | ($1.07) | ($0.79) | ($2.35) | | ($1.55) |
| Growth | 34.4% | -66.3% | | | |
| |
| Shares outstanding (basic) [+] | 31.5 | 28.0 | 5.5 | | 4.9 |
| Growth | 12.6% | 409.7% | | | |
| Shares outstanding (diluted) [+] | 31.5 | 28.0 | 5.5 | | 4.9 |
| Growth | 12.6% | 409.7% | | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|